miR-30e* is an independent subtype-specific prognostic marker in breast cancer.

Br J Cancer · 2015 · PMC4506390 · PMID 26057454

Europe PMC DOI

hedged sentence

0.1270

closest p · 2.5× alpha

0.1270

boldest claim

The sentences

only marginally significantP -value=0.127not close (p > 0.1)

In the subgroup, miR-30e* showed a HR similar to that observed in treated women with ESR1+/ERBB2− primaries, although the protective effect associated with higher miR-30e* expression was only marginally significant probably due to the reduced sample size (HR=0.710, P -value=0.127).

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.